NASDAQ: RGENRepligen Revenue
Repligen revenue was $707.89M for the trailing 12 months ending Sep 30, 2025, with N/A growth year over year. Quarterly revenue for the quarter (Q3 2025) ending on Sep 30, 2025 was $188.8M, up 3.5% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, RGEN annual revenue was $634.4M, with 0.3% growth year-over-year.
RGEN past revenue growth
How has RGEN's revenue growth performed historically?
Company
11.74%
Industry
13.74%
Market
23.08%
RGEN's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
RGEN's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
RGEN's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance
RGEN revenue history
Current Revenue
$707.9M
Current Earnings
$1.7M
Current Profit Margin
0.2%
RGEN's has not demonstrated consistent... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance
Be the first to know when RGEN announces revenue.
RGEN Revenue History By Year
| RGEN Yearly Revenue | RGEN Revenue | RGEN Change | RGEN Revenue Growth |
|---|---|---|---|
| 2024-12-31 | $634.44M | $2.08M | +0.33% |
| 2023-12-31 | $632.36M | -$169.17M | -21.11% |
| 2022-12-31 | $801.54M | $131.00M | +19.54% |
| 2021-12-31 | $670.53M | $304.27M | +83.08% |
| 2020-12-31 | $366.26M | $96.02M | +35.53% |
| 2019-12-31 | $270.25M | $76.21M | +39.28% |
| 2018-12-31 | $194.03M | $52.80M | +37.38% |
| 2017-12-31 | $141.24M | $36.70M | +35.10% |
| 2016-12-31 | $104.54M | $21.00M | +25.14% |
| 2015-12-31 | $83.54M | $19.99M | +31.45% |
| 2014-12-31 | $63.55M | -$4.62M | -6.78% |
| 2013-12-31 | $68.17M | $5.90M | +9.48% |
| 2012-12-31 | $62.27M | $34.98M | +128.16% |
| 2011-03-31 | $27.29M | $6.32M | +30.14% |
| 2010-03-31 | $20.97M | -$8.39M | -28.58% |
| 2009-03-31 | $29.36M | $10.07M | +52.16% |
| 2008-03-31 | $19.30M | $5.22M | +37.10% |
| 2007-03-31 | $14.07M | $1.16M | +9.01% |
| 2006-03-31 | $12.91M | $3.55M | +37.94% |
| 2005-03-31 | $9.36M | $2.45M | +35.38% |
| 2004-03-31 | $6.91M | -$857.44k | -11.03% |
| 2003-03-31 | $7.77M | $3.47M | +80.67% |
| 2002-03-31 | $4.30M | $2.05M | +90.74% |
| 2001-03-31 | $2.26M | -$648.72k | -22.34% |
| 2000-03-31 | $2.90M | $526.46k | +22.14% |
| 1999-03-31 | $2.38M | -$7.57k | -0.32% |
| 1998-03-31 | $2.38M | -$1.42M | -37.26% |
| 1997-03-31 | $3.80M | -$7.06M | -64.99% |
| 1996-03-31 | $10.86M | -$6.08M | -35.91% |
| 1995-03-31 | $16.94M | -$9.89M | -36.86% |
| 1994-03-31 | $26.83M | N/A | N/A |
Repligen Revenue FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.